• [email protected]
  • +971 507 888 742
Submit Manuscript
SciAlert
  • Home
  • Journals
  • Information
    • For Authors
    • For Referees
    • For Librarian
    • For Societies
  • Contact
  1. Singapore Journal of Scientific Research
  2. Vol 1 (1), 2011
  3. 13-22
  • Online First
  • Current Issue
  • Previous Issues
  • More Information
    Aims and Scope Editorial Board Guide to Authors Article Processing Charges
    Submit a Manuscript

Singapore Journal of Scientific Research

Year: 2011 | Volume: 1 | Issue: 1 | Page No.: 13-22

Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Article Trend



Total views 359

Search


Authors


C.M. Sultanpur

Country: India

S.V. Kumar

Country: India

K. Deepa

Country: India

Keywords


  • angiotensin II
  • Hypertension
  • renin
  • angiotensin I
  • vaccine
Review Article

Vaccines for Hypertension Disorder: Beneficial or Detrimental

C.M. Sultanpur, S.V. Kumar and K. Deepa
The prevalence of hypertension in the adult population was estimated to be 26.4% in 2000 and is projected to be 29.2% by 2025. Hypertension significantly increases the risk of developing disorders such as coronary artery disease, stroke, arrhythmia, heart failure, abnormal renal function and many other complications associated with structural damage to the cardiovascular system, hence the management of hypertension is very essential. Management of hypertension involves different approaches like life style modification and antihypertensive therapy. Life style modifications like weight reduction, discontinue smoking, limiting alcohol intake, increasing physical activity, reducing salt intake, increasing fruit vegetable intake, decreasing saturated and total fat intakes helps in managing hypertension. Antihypertensive therapy without co-morbidities involves administration of different classes of drugs like diuretics, angiotensin convertase enzyme, angiotensin receptor blockers, β blockers, calcium channel blockers, aldosterone antagonist and rennin inhibitors to achieve desired blood pressure intiating treatment with two drug combination may allow blood pressure targets to be reached earlier than monotherapy. This may lead to various adverse effects. Both the approaches requires patient adherence, which is a major problem in management of hypertension. To overcome the problem of patient compliance, research is going on the development of vaccines for hypertension, which produces antibodies against endogenous renin/angiotensin I and II. Vaccines for treatment of hypertension unlike other conventional, vaccine which is used for prevention of various diseases. Although, the concept is intriguing because excessive stimulation of immune system against endogenous substance may lead to autoimmune disorder like nephritis and also renin angiotensin system involved in the maintaining of homeostasis will be hampered. It’s better to use many excellent therapeutic options that are already available to inhibit the RAS, until efficient vaccine is developed.
PDF Fulltext XML References Citation

How to cite this article

C.M. Sultanpur, S.V. Kumar and K. Deepa, 2011. Vaccines for Hypertension Disorder: Beneficial or Detrimental. Singapore Journal of Scientific Research, 1: 13-22.

URL: https://scialert.net/abstract/?doi=sjsres.2011.13.22

Related Articles

Influence of Brine Concentration and Ripening Temperature on Quality of Sharri Cheese
Salt in Cheese: A Review
Influence of Bosentan on Antidiabetic Effect of Pioglitazone and Nateglinide in Experimental Animals

Leave a Comment


Your email address will not be published. Required fields are marked *

Useful Links

  • Journals
  • For Authors
  • For Referees
  • For Librarian
  • For Socities

Contact Us

Office Number 1128,
Tamani Arts Building,
Business Bay,
Deira, Dubai, UAE

Phone: +971 507 888 742
Email: [email protected]

About Science Alert

Science Alert is a technology platform and service provider for scholarly publishers, helping them to publish and distribute their content online. We provide a range of services, including hosting, design, and digital marketing, as well as analytics and other tools to help publishers understand their audience and optimize their content. Science Alert works with a wide variety of publishers, including academic societies, universities, and commercial publishers.

Follow Us
© Copyright Science Alert. All Rights Reserved